Welcome to LookChem.com Sign In|Join Free
  • or
2-(3',4'-dimethoxybenzylidene)-6,7-dimethoxy-3,4-dihydronaphthalen-1(2H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

107446-44-6

Post Buying Request

107446-44-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

107446-44-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 107446-44-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,7,4,4 and 6 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 107446-44:
(8*1)+(7*0)+(6*7)+(5*4)+(4*4)+(3*6)+(2*4)+(1*4)=116
116 % 10 = 6
So 107446-44-6 is a valid CAS Registry Number.

107446-44-6Relevant academic research and scientific papers

Rational design, synthesis and structure-activity relationships of antitumor (E)-2-benzylidene-1-tetralones and (E)-2-benzylidene-1-indanones

Shih, Hsiencheng,Deng, Lynn,Carrera, Carlos J.,Adachi, Souichi,Cottam, Howard B.,Carson, Dennis A.

, p. 487 - 490 (2007/10/03)

Novel substituted 6,7-dimethoxy-1-tetralones and 5,6-dimethoxy-1-indanones have been synthesized and evaluated for their cytotoxicity. Compounds with 3'-lipophilic, 3',5'-dilipophilic, or 3',5'-dilipophilic-4'-hydrophilic substituents on (E)-2-benzylidene moiety showed highly cytotoxic effects. The unique structure of 42 possibly matches the pharmacophore features for these cytotoxic compounds. (C) 2000 Elsevier Science Ltd. All rights reserved.

Indanone and tetralone compounds for inhibiting cell proliferation

-

, (2008/06/13)

A new family of indanone and tetralone tubulin-binding compounds (TBs) is disclosed. Unlike classical TBs, which inhibit mitosis among affected dividing cells, the TBs of the invention possess two unique properties: (1) they induce apoptosis among stationary phase (non-dividing) malignant cells, yet do not impair the viability of normal nonproliferating cells; and, (2) they affect cells which have acquired MDR more powerfully than they affect cells without MDR. Thus, the TBs of the invention provide means to target malignant cells for chemotherapy, even after previous therapies have failed, without affecting normal cells and tissues in the host.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 107446-44-6